Transcatheter Aortic Valve Replacement (TAVR)

Contact Interventional Cardiology

For more information or to refer a patient, please call 401-606-1004 or visit cviri.org

Providing Hope to Patients with Severe Aortic Valve Stenosis

Transcatheter aortic valve replacement (TAVR) offers a lifesaving option to patients who have severe aortic valve stenosis, but who are not candidates for open heart surgery due to advanced age or existing medical conditions.

The Cardiovascular Institute of Rhode Island, The Miriam and Newport hospitals was the first program in Rhode Island and among the first in New England to provide this less invasive alternative to open heart surgery.

Our TAVR program is helping patients live longer with an improved quality of life.

TAVR
A replacement valve

What is Aortic Stenosis?

Aortic stenosis is a progressive disease that affects approximately 1.5 million people in the United States. Approximately 500,000 of these patients suffer from severe aortic stenosis, which can restrict normal daily activities, such as walking short distances or climbing stairs, and can cause sudden death.

About the Procedure

Aortic valve stenosis—the hardening and narrowing of the aortic valve inside the heart—forces the heart to work harder to pump blood through the body. Ultimately, the condition can weaken the heart and lead to congestive heart failure and death.

Lifespan Cardiovascular Institute physicians use the procedure to replace narrowed and diseased aortic heart valves with artificial valves. The new valve is fed into the aorta using a catheter inserted through a small incision into a blood vessel in either the thigh or chest. Patients who undergo the TAVR procedure will, on average, spend less than a week in the hospital and should make a full recovery within two to four weeks.Our TAVR procedures are precisely orchestrated by a world-renowned, multidisciplinary TAVR team led by interventional cardiologists and cardiovascular surgeons.